Q: Why have some diabetes medications turned into weight-loss medications
doi: 10.1016/j.ejps.2017.03.020 [DOI] [PubMed] [Google Scholar] 73.Schneck K, Urva S
Why duration varies between patients Metabolism: Faster metabolism wears toxin off quicker Muscle mass: Stronger muscles tend to outpace toxin sooner Exercise level: High-volume aerobic exercise (regular running, intense gym work) tends to shorten duration Treatment history: First-time patients often see shorter duration than long-term regulars Dosing: Conservative dosing tends to wear off slightly sooner than higher dosing Genetic factors: Some patients genuinely metabolise toxin faster than others Cumulative benefit over time With regular treatment 34 times per year, several beneficial patterns emerge: Each treatment tends to last slightly longer than the last as muscles retrain Static lines that were already present often soften because the underlying muscle activity that was deepening them is reduced Patients who have maintained treatment for 5+ years tend to have visibly fewer permanent lines than peers who have not Dosing per area sometimes reduces over time as cumulative effect builds What good results look like A well-treated patient looks rested, relaxed, and themselves not frozen, not surprised, not suspiciously line-free
Wegovy primarily focuses on the GLP-1 receptor, while Zepbound targets multiple receptors (GLP-1, GIP, and glucagon), which may offer additional benefits for appetite suppression and energy expenditure
Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer
